01 1Chromo Laboratories
01 1OLMESARTAN MEDOXOMIL USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2023-08-15
Pay. Date : 2023-06-26
DMF Number : 33587
Submission : 2019-04-13
Status : Active
Type : II
20
Chromo Laboratories India Private Ltd, based in India, is a pharmaceutical company.
One of their notable products is OLMESARTAN MEDOXOMIL USP, with a corresponding US DMF Number 33587.
Remarkably, this DMF maintains an Active status since its submission on April 13, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 15, 2023, and payment made on June 26, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II
